Publications of Mariana Juárez-Osorio

Ruhnau, J., Grote, V., Juárez-Osorio, M., Bruder, D., Mahour, R., Rapp, E., Rexer, T., & Reichl, U. (2021)Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike GlycoproteinFrontiers in Bioengineering and Biotechnology, 9, 699026doi: 10.3389/fbioe.2021.699025.

Rudert, J., Bälkner, M., Juárez-Osorio, M., Rexer, T., Reichl, U., Jacobsen, H., Metzdorf, K., Bruder, D., & Volckmar, J. (2023)Adjuvanted SARS-CoV-2 spike protein vaccination with altered glycosylation elicits improved TH1 humoral and cellular immunity in miceIn: European Journal of Immunology, P376doi: 10.1002/eji.202370300.

Rexer, T., Hoang Son, T., Alcalá Orozco, E. A., Juárez-Osorio, M., Kleeberg, S., & Reichl, U.Activated sugar for oligosaccharides synthesisPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U.Towards full control over protein glycosylation: In-vitro glycoengineering of Influenza A virus Hemagglutinin and SARS-CoV-2 spike proteinPresented at: 32^nd Joint Glycobiology MeetingUtrecht (The Netherlands), September 18, 2022.

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U.Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike proteinPresented at: GlycoBioTec 2023Berlin, Germany, January 16, 2023.

Ruhnau, J., Grote, V., Juárez-Osorio, M., Bruder, D., Mahour, R., Rapp, E., Rexer, T., & Reichl, U.Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike GlycoproteinPresented at: glycoNET2021virtually, September 22, 2021.